These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6996464)

  • 1. Transfer factor: specific and nonspecific effects and chemical characteristics of dialyzable leukocyte lysates (DLL). Part I. Introduction. (first of three parts).
    Ablin RJ
    Allergol Immunopathol (Madr); 1980; 8(1):53-60. PubMed ID: 6996464
    [No Abstract]   [Full Text] [Related]  

  • 2. Transfer factor: specific and nonspecific effects and chemical characteristics of dialyzable leukocyte lysates (DLL). Part II. Reconstituting effects dialyzable leukocyte lysates. (Second of three parts).
    Schindler TE; Baram P
    Allergol Immunopathol (Madr); 1980; 8(2):125-9. PubMed ID: 7457287
    [No Abstract]   [Full Text] [Related]  

  • 3. Transfer factor: specific and nonspecific effects and chemical characteristics of dialyzable leukocyte lysates (DLL). Part III. Biochemical characterization. (third of three parts).
    Ablin RJ
    Allergol Immunopathol (Madr); 1980; 8(3):203-12. PubMed ID: 7405767
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of dialyzable products from human leukocyte extracts on cutaneous delayed-hypersensitivity response.
    Gottlieb AA; Maziarz GA; Tamaki N; Sutcliffe SB
    J Immunol; 1980 Feb; 124(2):885-92. PubMed ID: 7356716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transfer of delayed type hypersensitivity in guinea pigs].
    Smogorzewska E
    Probl Med Wieku Rozwoj; 1990; 16():167-88. PubMed ID: 2152405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial transfer of delayed hypersensitivity with dialyzable transfer factor.
    Kirkpatrick CH; Smith TK
    Cell Immunol; 1976 Dec; 27(2):323-7. PubMed ID: 795550
    [No Abstract]   [Full Text] [Related]  

  • 7. Distinct components in dialyzable leukocyte extracts (DLE) have specific and nonspecific effects on cellular immunity as shown by leukocyte migration inhibition.
    Wilson GB; Fudenberg HH; Bahm VJ
    Trans Assoc Am Physicians; 1978; 91():295-332. PubMed ID: 754397
    [No Abstract]   [Full Text] [Related]  

  • 8. Murine transfer factor. II. Transfer of delayed hypersensitivity to synthetic antigens.
    Kirkpatrick CH; Rozzo SJ; Mascali JJ; Merryman CF
    J Immunol; 1985 Mar; 134(3):1723-7. PubMed ID: 2578518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine transfer factor: in vivo transfer of cell-mediated immunity to cattle with alcohol precipitates.
    Klesius PH; Fudenberg HH
    Clin Immunol Immunopathol; 1977 Sep; 8(2):238-46. PubMed ID: 902438
    [No Abstract]   [Full Text] [Related]  

  • 10. [The isolation of a transfer factor of the delayed-hypersensitivity type to the antigenic substances of Staphylococcus aureus in guinea pigs].
    Holieva OH; Liubchenko TA; Kholodna LS; Vershihora AIu
    Fiziol Zh (1994); 1996; 42(5-6):58-65. PubMed ID: 9044813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Human specific transfer factor to Staphylococcus aureus antigens].
    Liubchenko TA; Holeva OH; Kholodna LS; Stepanchuk VA; Vershyhora AIu
    Fiziol Zh (1994); 1997; 43(3-4):25-32. PubMed ID: 9303798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies on dialyzable leukocyte extracts containing transfer factor--a review.
    Klesius PH; Fudenberg HH; Smith CL
    Comp Immunol Microbiol Infect Dis; 1980; 3(3):247-60. PubMed ID: 6162606
    [No Abstract]   [Full Text] [Related]  

  • 13. Transfer factor and its clinical application.
    Schulkind ML; Ayoub EM
    Adv Pediatr; 1980; 27():89-115. PubMed ID: 7013447
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfer factor therapy in immunodeficiency.
    Griscelli C
    Birth Defects Orig Artic Ser; 1975; 11(1):462-4. PubMed ID: 1148388
    [No Abstract]   [Full Text] [Related]  

  • 15. [The adjuvant and specific activity of transfer factors to Candida albicans antigens].
    Borysov VA; Cheusova ZV; Molozhava OS
    Fiziol Zh (1994); 1998; 44(4):3-9. PubMed ID: 9669168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of cell-mediated responses with dialyzable leukocyte extract containing transfer factor.
    Klesius PH
    Adv Exp Med Biol; 1981; 137():293-323. PubMed ID: 6174037
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell-mediated immunity: correlation of mixed-leucocyte-macrophage migration inhibition with delayed-type hypersensitivity after immunization and donor-specific transfer of cell migration inhibition by dialyzable leucocyte extract.
    Mazaheri R; Hamblin AS; Zuckerman AJ
    Cell Immunol; 1983 Nov; 82(1):147-62. PubMed ID: 6196129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-specificity of transfer factor.
    Khan A
    Ann Allergy; 1977 May; 38(5):320-2. PubMed ID: 855952
    [No Abstract]   [Full Text] [Related]  

  • 19. Reactions in canine skin with human leukocyte lysates.
    Tomar RH; Terzian J
    Proc Soc Exp Biol Med; 1977 Nov; 156(2):247-50. PubMed ID: 73187
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current views on the mechanism of immunological disorders in Hodgkin's disease].
    Voĭtenkov BO; Letskiĭ VB; Gavrilenkova LP
    Eksp Onkol; 1984; 6(4):17-22. PubMed ID: 6389087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.